Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-22-029030

Chief Executive Officer bought 10,500 shares at $0.25 ($2,625)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-16 Purchase : show line 1 in the form +10,500 $0.25 $2,625 94,430 D
Open-market purchases · 10,500 sh · avg $0.25 · $2,625
Loading xslF345X03/doc4.xml…